europe

Growing controversy over role of FDA and Medicare in promoting anti-amyloid drugs given limited benefit, high cost, severe side-effects

by

The War Over Whether Medicare Should Pay For The New Anti-Alzheimer’s Drugs (Forbes):

The pow­er­ful Alzheimer’s Dis­ease lob­by is fight­ing a mul­ti-bil­lion-dol­lar bat­tle on two fronts. It is qui­et­ly try­ing to lim­it restric­tions the Food and Drug Admin­is­tra­tion puts on the use of new drugs aimed at slow­ing the pro­gres­sion of the brain dis­ease. And it is pub­licly press­ing Medicare to pay for the wide­spread use of the mon­o­clon­al anti­bod­ies FDA already has con­di­tion­al­ly approved as well as oth­ers in the pipeline. [Read more…] about Grow­ing con­tro­ver­sy over role of FDA and Medicare in pro­mot­ing anti-amy­loid drugs giv­en lim­it­ed ben­e­fit, high cost, severe side-effects

Latest brain research, tools and teasers to think outside the mental health status quo box

by

__

Time for a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing a range of  research find­ings, resources, brain teasers and rid­dles to help trans­late emerg­ing neu­ro­science into real-world appli­ca­tions and improve our col­lec­tive brain & men­tal health.

New thinking:

New research:

New tools:

Fun brain teasers:

 

Have a great month of March,

 

The Sharp­Brains Team

New $3m European-Israeli collaboration to build brain training system and enhance football (soccer) players’ game intelligence

by

horizon-2020_football_brain-training.

The ini­tial pilot, fund­ed under the EU Hori­zon 2020 frame­work and to be com­plet­ed by 2017, will start with lead­ing Euro­pean soc­cer acad­e­mies includ­ing Ajax Ams­ter­dam, PSV Eind­hoven, AZ Alk­maar and FC Freiburg, in col­lab­o­ra­tion with the Sports Uni­ver­si­ty in Cologne, Ger­many. [Read more…] about New $3m Euro­pean-Israeli col­lab­o­ra­tion to build brain train­ing sys­tem and enhance foot­ball (soc­cer) play­ers’ game intelligence

June 22nd talk @ Fundacion Edad y Vida (Barcelona) on Health in the XXI century

by

aa-225x300Last Novem­ber, talk­ing with some Japan­ese col­leagues at the World Eco­nom­ic Forum’s Coun­cil on the Aging Soci­ety, I dis­cov­ered that it is com­mon there to orga­nize research-dri­ven consortia/ learn­ing labs among for-prof­it, non-prof­it and aca­d­e­m­ic orga­ni­za­tions inter­est­ed in the devel­op­ment of “sil­ver indus­tries”, this is, where com­pa­nies devel­op prod­uct and ser­vices spe­cif­ic to the needs of old­er adults.

I just dis­cov­ered ‑hav­ing been invit­ed to speak there, togeth­er with Prof. Shlo­mo Breznitz- that my native Spain counts with a sim­i­lar inno­v­a­tive plat­form. You can see below (in Span­ish) the details of my tak in Barcelona on June 22nd, and here you have how the Fun­da­cion Edad y Vida describes itself:

  • The Edad&Vida Foun­da­tion is a plat­form where all the dif­fer­ent agents involved in con­tribut­ing to the qual­i­ty of life of elder­ly peo­ple con­verge. Edad&Vida is an open space to com­pa­nies from dif­fer­ent eco­nom­ic sec­tors, social agents and aca­d­e­m­ic entities.
  • Edad&Vida is the result of the effort of more than 40 lead­ing com­pa­nies that belong to dif­fer­ent eco­nom­ic sec­tors. We can find [Read more…] about June 22nd talk @ Fun­da­cion Edad y Vida (Barcelona) on Health in the XXI century